📰 Beigene News
Page 6 - Beigene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.
September 12, 2023
Stock analysts at Royal Bank of Canada started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The firm set an “outperform” rating and a $259.00 price target on the stock. Royal Bank of Canada’s price target would suggest a potential upside of […]
September 11, 2023
Analysts at Macquarie assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research note issued on Monday, FlyOnTheWall reports. The firm set an “outperform” rating on the stock. BGNE has been the topic of several other research reports. Morgan Stanley decreased their price objective on BeiGene from $321.00 to $319.00 and […]
September 1, 2023
BeiGene (NASDAQ:BGNE – Free Report) had its price target cut by Morgan Stanley from $321.00 to $319.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the stock. A number of other analysts have also weighed in on BGNE. 22nd Century Group reaffirmed a downgrade rating on shares […]
August 19, 2023
StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research note issued to investors on Thursday. The firm set a “hold” rating on the stock. Other analysts have also issued research reports about the company. JPMorgan Chase & Co. upped their price objective on BeiGene from $297.00 to $300.00 and […]
August 18, 2023
StockNews.com started coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the stock. Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. raised their target price on shares of BeiGene from $297.00 to $300.00 and […]
August 17, 2023
Equities researchers at Jefferies Financial Group started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $287.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 49.22% from the company’s […]
August 14, 2023
Shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) rose 4% on Monday . The stock traded as high as $206.48 and last traded at $205.63. Approximately 77,738 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 226,629 shares. The stock had previously closed at $197.68. Analyst Ratings […]
August 3, 2023
By Denny Jacob International stocks trading in New York closed lower on Wednesday. The S&P/BNY Mellon index of American depositary receipts retreated 2.2% to...
August 2, 2023
BASEL, Switzerland, BEIJING, & CAMBRIDGE, Mass., August 02, 2023--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today reported financial results from the second quarter of 2023 and business highlights.
July 24, 2023
BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]